Farms.com Home   News

University of Georgia academics receive $15.8m for poplar-focused bioenergy research

A multidisciplinary team of researchers at the University of Georgia and two partner institutions have been awarded a $15.8 million (€16m) grant over five years from the US Department of Energy (DOE) to reengineer poplar trees (Populus sp. and hybrids) to be used as a sustainable energy source, reported UGA Today. The grant forms part of a larger $178m (€180.8m) DOE initiative to develop bioenergy technology.

The institution said that researchers will utilise state-of-the-art biotechnology methods to breed the trees as a multi-purpose crop. They will then be implemented for bioenergy, biomaterial and bioproduct alternatives to petroleum-based materials.
“Currently, there is a growing need for sustainable sources of not only biofuels but also bioproducts and plant-based materials. Poplars are among the fastest growing trees in the United States and are important for both carbon sequestration and global carbon cycling,” said Robin Buell, principal investigator on the grant and the GRA Eminent Scholar Chair in Crop Genomics at the Centre for Applied Genetic Technologies in the College of Agricultural and Environmental Sciences.

Five projects will be funded via the UGA grant involving Buell and UGA faculty collaborators . These include Wayne Parrott in the CAES Department of Crop and Soil Sciences; Chung-Jui Tsai and Bob Schmitz in the Department of Genetics; and Breeanna Urbanowicz in the Department of Biochemistry and Molecular Biology, all in UGA’s Franklin College of Arts and Sciences. External collaborators are Patrick Shih at University of California, Berkeley, and Chris Dardick with the US Department of Agriculture’s Agricultural Research Service.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.